Holdings of Tema Oncology ETF
Tema ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 176.1M $ including 174.4M $ in equities, 99.0 %
- Positions
- 56 in 8 countries
- Top ten
- 42.9 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | 86,450 | 13.6M $ | 7.73 % |
| 2 | Eli Lilly & Co | 7,684 | 8.5M $ | 4.82 % |
| 3 | Roche Holding AG | 141,653 | 7.4M $ | 4.21 % |
| 4 | COGENT BIOSCIENCES INC | 206,419 | 7.2M $ | 4.10 % |
| 5 | Novartis AG | 47,020 | 7.1M $ | 4.03 % |
| 6 | Immunome Inc | 315,648 | 6.9M $ | 3.91 % |
| 7 | Celcuity Inc | 47,450 | 6.3M $ | 3.58 % |
| 8 | Merck & Co Inc | 52,978 | 6.3M $ | 3.57 % |
| 9 | AstraZeneca PLC | 33,501 | 6.2M $ | 3.54 % |
| 10 | Nuvalent Inc | 53,763 | 5.9M $ | 3.37 % |
| 11 | Bristol-Myers Squibb Co | 101,680 | 5.8M $ | 3.30 % |
| 12 | LEGEND BIOTECH CORP | 194,092 | 5.3M $ | 2.99 % |
| 13 | AbbVie Inc | 22,700 | 4.9M $ | 2.81 % |
| 14 | Exelixis Inc | 96,885 | 4.9M $ | 2.78 % |
| 15 | Bridgebio Pharma Inc | 73,191 | 4.8M $ | 2.75 % |
| 16 | Johnson & Johnson | 19,900 | 4.5M $ | 2.55 % |
| 17 | CG ONCOLOGY INC | 68,702 | 4.3M $ | 2.43 % |
| 18 | Genmab A/S | 158,861 | 4.2M $ | 2.37 % |
| 19 | Ideaya Biosciences Inc | 135,847 | 4M $ | 2.27 % |
| 20 | Amgen Inc | 11,019 | 3.7M $ | 2.11 % |
| 21 | ZAI LAB LTD | 196,972 | 3.5M $ | 1.98 % |
| 22 | BEONE MEDICINES LTD | 11,505 | 3.3M $ | 1.88 % |
| 23 | Zymeworks Inc | 105,615 | 2.7M $ | 1.51 % |
| 24 | Enliven Therapeutics Inc | 58,197 | 2.3M $ | 1.31 % |
| 25 | Relay Therapeutics Inc | 161,076 | 2.3M $ | 1.28 % |
| 26 | Halozyme Therapeutics Inc | 32,598 | 2.2M $ | 1.23 % |
| 27 | Summit Therapeutics Inc | 121,097 | 2.1M $ | 1.21 % |
| 28 | ARCUS BIOSCIENCES INC | 83,140 | 2.1M $ | 1.20 % |
| 29 | Gilead Sciences Inc | 14,692 | 2M $ | 1.12 % |
| 30 | IMMATICS NV | 171,499 | 2M $ | 1.12 % |
| 31 | Erasca Inc | 147,828 | 1.9M $ | 1.08 % |
| 32 | Nuvation Bio Inc | 395,313 | 1.9M $ | 1.07 % |
| 33 | AnaptysBio Inc | 31,270 | 1.7M $ | 0.99 % |
| 34 | UroGen Pharma Ltd | 58,518 | 1.6M $ | 0.93 % |
| 35 | GUARDANT HEALTH INC | 10,986 | 1.4M $ | 0.81 % |
| 36 | Syndax Pharmaceuticals Inc | 72,212 | 1.4M $ | 0.80 % |
| 37 | Corvus Pharmaceuticals Inc | 108,477 | 1.3M $ | 0.76 % |
| 38 | Regeneron Pharmaceuticals Inc | 2,138 | 1.3M $ | 0.75 % |
| 39 | ArriVent Biopharma Inc | 42,744 | 1.3M $ | 0.73 % |
| 40 | Chugai Pharmaceutical Co Ltd | 23,697 | 1.2M $ | 0.67 % |
| 41 | Iovance Biotherapeutics Inc | 280,048 | 1.1M $ | 0.65 % |
| 42 | Inhibrx Biosciences Inc | 10,170 | 1.1M $ | 0.60 % |
| 43 | Olema Pharmaceuticals Inc | 79,759 | 1.1M $ | 0.60 % |
| 44 | Cullinan Therapeutics Inc | 62,826 | 1M $ | 0.59 % |
| 45 | NATERA INC | 4,238 | 946.6K $ | 0.54 % |
| 46 | First Tracks Biotherapeutics Inc | 58,419 | 932.4K $ | 0.53 % |
| 47 | Immunocore Holdings PLC | 30,849 | 891.2K $ | 0.51 % |
| 48 | BridgeBio Oncology Therapeutics Inc | 93,339 | 837.3K $ | 0.48 % |
| 49 | CYTOMX THERAPEUTICS INC | 228,987 | 824.4K $ | 0.47 % |
| 50 | HUTCHMED China Ltd | 67,823 | 776.6K $ | 0.44 % |
| 51 | Arvinas Inc | 84,124 | 755.4K $ | 0.43 % |
| 52 | Janux Therapeutics Inc | 51,522 | 751.7K $ | 0.43 % |
| 53 | ADLAI NORTYE LTD | 44,354 | 529.6K $ | 0.30 % |
| 54 | TYRA BIOSCIENCES INC | 15,780 | 527.2K $ | 0.30 % |
| 55 | ORIC Pharmaceuticals Inc | 57,977 | 489.9K $ | 0.28 % |
| 56 | SELLAS Life Sciences Group Inc | 40,702 | 378.9K $ | 0.22 % |
Sector breakdown
- Health care 33.7 %
- Unattributed 66.3 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 91.7 %
- CHF 4.1 %
- GBP 3.6 %
- JPY 0.7 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 77.2 %
- Switzerland 8.3 %
- Cayman Islands 5.8 %
- United Kingdom 3.6 %
- Denmark 2.4 %
- Netherlands 1.1 %
- Israel 0.9 %
- Japan 0.7 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 45 | 134.6M $ | 77.18 % |
| 2 | Switzerland | 2 | 14.5M $ | 8.33 % |
| 3 | Cayman Islands | 4 | 10.1M $ | 5.77 % |
| 4 | United Kingdom | 1 | 6.2M $ | 3.57 % |
| 5 | Denmark | 1 | 4.2M $ | 2.40 % |
| 6 | Netherlands | 1 | 2M $ | 1.13 % |
| 7 | Israel | 1 | 1.6M $ | 0.94 % |
| 8 | Japan | 1 | 1.2M $ | 0.67 % |
Cite this page
Titelia. "Holdings of Tema Oncology ETF". https://titelia.com/en/funds/S000078299